SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021685
Filing Date
2020-11-16
Accepted
2020-11-16 16:15:38
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 798639
2 ex10-1.htm EX-10.1 19258
3 ex31.htm EX-31 37143
4 ex32.htm EX-32 9155
  Complete submission text file 0001493152-20-021685.txt   4223465

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE age-20200930.xml EX-101.INS 762788
6 XBRL SCHEMA FILE age-20200930.xsd EX-101.SCH 40614
7 XBRL CALCULATION FILE age-20200930_cal.xml EX-101.CAL 61253
8 XBRL DEFINITION FILE age-20200930_def.xml EX-101.DEF 189725
9 XBRL LABEL FILE age-20200930_lab.xml EX-101.LAB 300357
10 XBRL PRESENTATION FILE age-20200930_pre.xml EX-101.PRE 264700
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 201317099
SIC: 2834 Pharmaceutical Preparations